Novogene Co Ltd Class A 688315
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 14.13
- Day Range
- CNY 13.94–14.45
- 52-Week Range
- CNY 12.17–35.70
- Bid/Ask
- CNY 14.30 / CNY 14.31
- Market Cap
- CNY 5.95 Bil
- Volume/Avg
- 2.8 Mil / 2.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- 42.94
- Price/Sales
- 2.84
- Dividend Yield (Trailing)
- 0.33%
- Dividend Yield (Forward)
- 0.33%
- Total Yield
- 0.33%
Company Profile
Novogene Co Ltd is engaged in providing multi-level scientific research and technical services and solutions for life science basic research, medical and clinical application research, and independent development and innovation of genetic testing medical equipment.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Core
- Total Number of Employees
- 2,144
- Website
- https://en.novogene.com
Comparables
Valuation
|
Metric
|
688315
|
000710
|
688253
|
|---|---|---|---|
Price/Earnings (Normalized) | 42.94 | — | 20.72 |
Price/Book Value | 2.42 | 1.64 | 2.47 |
Price/Sales | 2.84 | 2.79 | 7.90 |
Price/Cash Flow | 22.99 | 29.28 | 11.96 |
Price/Earnings
688315
000710
688253
Financial Strength
|
Metric
|
688315
|
000710
|
688253
|
|---|---|---|---|
Quick Ratio | 1.86 | 1.63 | 10.60 |
Current Ratio | 2.40 | 2.02 | 11.04 |
Interest Coverage | 109.58 | — | 1,693.02 |
Quick Ratio
688315
000710
688253
Profitability
|
Metric
|
688315
|
000710
|
688253
|
|---|---|---|---|
Return on Assets (Normalized) | 5.06% | −2.24% | 4.47% |
Return on Equity (Normalized) | 7.69% | −3.20% | 4.81% |
Return on Invested Capital (Normalized) | 7.55% | −2.73% | 4.51% |
Return on Assets
688315
000710
688253
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Dbnfmkgrmw | Qby | $566.6 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Xgxqwrg | Sffbdn | $102.4 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Hhngkglr | Jlmmfr | $98.3 Bil | |
MRNA
| Moderna Inc | Pjpcmxqs | Wfznq | $42.7 Bil | |
ARGX
| argenx SE ADR | Wccnzhllb | Qlyxw | $22.2 Bil | |
BNTX
| BioNTech SE ADR | Cbbzwxnqf | Hsbv | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Mmyhvwk | Xklncg | $18.6 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Pnkwfdhc | Qjkfhr | $15.6 Bil | |
RPRX
| Royalty Pharma PLC Class A | Lfwyxffx | Gvlqggq | $12.7 Bil | |
INCY
| Incyte Corp | Jztflmhlf | Wcclbv | $11.8 Bil |